| Primary |
| Product Used For Unknown Indication |
34.2% |
| Type 2 Diabetes Mellitus |
31.6% |
| Diabetes Mellitus |
14.7% |
| Drug Use For Unknown Indication |
2.7% |
| Hypertension |
1.8% |
| Insulin-requiring Type 2 Diabetes Mellitus |
1.8% |
| Atrial Fibrillation |
1.3% |
| Dyslipidaemia |
1.3% |
| Dyspnoea |
1.3% |
| Hyperuricaemia |
1.3% |
| Pyrexia |
1.3% |
| Rhinitis |
1.3% |
| Cardiac Failure |
0.9% |
| Cerebral Infarction |
0.9% |
| Radiation Oesophagitis |
0.9% |
| Type 1 Diabetes Mellitus |
0.9% |
| Angina Pectoris |
0.4% |
| Blood Glucose Increased |
0.4% |
| Bronchitis |
0.4% |
| Cardiac Disorder |
0.4% |
|
| Hypoglycaemia |
13.1% |
| Hypoglycaemic Coma |
13.1% |
| Sopor |
9.8% |
| Acute Generalised Exanthematous Pustulosis |
4.9% |
| Cytolytic Hepatitis |
4.9% |
| Eosinophilia |
4.9% |
| Hyperkalaemia |
4.9% |
| Malaise |
4.9% |
| Pruritus |
4.9% |
| Rash |
4.9% |
| Abdominal Pain |
3.3% |
| Acute Hepatic Failure |
3.3% |
| Cholestasis |
3.3% |
| Diarrhoea |
3.3% |
| Drug Intolerance |
3.3% |
| Nephropathy |
3.3% |
| Pulmonary Alveolar Haemorrhage |
3.3% |
| Renal Failure |
3.3% |
| Bladder Cancer |
1.6% |
| Bladder Neoplasm |
1.6% |
|
| Secondary |
| Product Used For Unknown Indication |
21.7% |
| Type 2 Diabetes Mellitus |
21.2% |
| Diabetes Mellitus |
20.7% |
| Hypertension |
10.7% |
| Drug Use For Unknown Indication |
7.9% |
| Haemolytic Uraemic Syndrome |
2.7% |
| Bipolar Disorder |
2.1% |
| Cardiac Failure |
2.0% |
| Ill-defined Disorder |
1.4% |
| Rheumatoid Arthritis |
1.3% |
| Atrial Fibrillation |
1.2% |
| Dyslipidaemia |
1.2% |
| Hypothyroidism |
1.1% |
| Premedication |
1.1% |
| Pain |
0.8% |
| Coronary Artery Disease |
0.7% |
| Dementia Alzheimer's Type |
0.6% |
| Hyperuricaemia |
0.6% |
| Infection |
0.6% |
| Benign Prostatic Hyperplasia |
0.5% |
|
| Hypoglycaemia |
24.4% |
| Thrombocytopenia |
6.5% |
| Malaise |
5.7% |
| Renal Failure |
5.7% |
| Vomiting |
5.7% |
| Hypoglycaemic Coma |
4.9% |
| Pancreatic Carcinoma Metastatic |
4.1% |
| Renal Failure Acute |
4.1% |
| Colitis |
3.3% |
| Dizziness |
3.3% |
| Drug Interaction |
3.3% |
| Hepatic Cirrhosis |
3.3% |
| Hepatitis |
3.3% |
| Interstitial Lung Disease |
3.3% |
| Leukocytoclastic Vasculitis |
3.3% |
| Medication Error |
3.3% |
| Myoclonus |
3.3% |
| Nephropathy |
3.3% |
| Pancreatitis Acute |
3.3% |
| Respiratory Failure |
3.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.5% |
| Drug Use For Unknown Indication |
15.9% |
| Type 2 Diabetes Mellitus |
14.9% |
| Hypertension |
13.3% |
| Diabetes Mellitus |
11.8% |
| Atrial Fibrillation |
2.2% |
| Pain |
2.2% |
| Prophylaxis |
2.2% |
| Rheumatoid Arthritis |
1.8% |
| Hypercholesterolaemia |
1.7% |
| Coronary Artery Disease |
1.3% |
| Dyslipidaemia |
1.3% |
| Bronchitis |
1.1% |
| Myocardial Infarction |
1.1% |
| Depression |
1.1% |
| Back Pain |
1.0% |
| Hepatitis C |
0.9% |
| Hypothyroidism |
0.9% |
| Thrombosis Prophylaxis |
0.9% |
| Multiple Myeloma |
0.8% |
|
| Renal Failure Acute |
14.3% |
| Vomiting |
8.9% |
| Colon Cancer Recurrent |
5.7% |
| Diabetes Mellitus Inadequate Control |
5.7% |
| Death |
5.4% |
| Thrombocytopenia |
5.0% |
| Weight Increased |
5.0% |
| Drug Interaction |
4.6% |
| Renal Failure |
4.6% |
| Anaemia |
4.3% |
| General Physical Health Deterioration |
3.9% |
| Lactic Acidosis |
3.9% |
| Lung Disorder |
3.9% |
| Pulmonary Embolism |
3.9% |
| Hyperglycaemia |
3.6% |
| Metastases To Liver |
3.6% |
| Urinary Tract Infection |
3.6% |
| Weight Decreased |
3.6% |
| Hypoglycaemia |
3.2% |
| International Normalised Ratio Increased |
3.2% |
|
| Interacting |
| Type 2 Diabetes Mellitus |
25.5% |
| Prostate Cancer Metastatic |
15.7% |
| Hypertension |
10.8% |
| Helicobacter Infection |
5.9% |
| Drug Use For Unknown Indication |
4.9% |
| Product Used For Unknown Indication |
4.9% |
| Diabetes Mellitus |
3.9% |
| Hormone Therapy |
3.9% |
| Pain |
3.9% |
| Osteomyelitis |
2.9% |
| Atrial Fibrillation |
2.0% |
| Bacterial Infection |
2.0% |
| Dyslipidaemia |
2.0% |
| Osteitis |
2.0% |
| Osteoporosis |
2.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.0% |
| Restless Legs Syndrome |
2.0% |
| Secondary Hyperthyroidism |
2.0% |
| Depression |
1.0% |
| Gastrooesophageal Reflux Disease |
1.0% |
|
| Hypoglycaemia |
42.1% |
| Hypoglycaemic Coma |
21.1% |
| Transaminases Increased |
10.5% |
| Drug Interaction |
5.3% |
| Drug Level Fluctuating |
5.3% |
| Myoclonus |
5.3% |
| Oedema Peripheral |
5.3% |
| Thrombocytopenia |
5.3% |
|
